Catalyst Pharmaceuticals (CPRX) Cash from Investing Activities Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.01% |
| Dec 31, 2024 | -14.90% |
| Sep 30, 2024 | -15.45% |
| Jun 30, 2024 | 74.85% |
| Mar 31, 2024 | -15.09% |
| Dec 31, 2023 | -36.33% |
| Sep 30, 2023 | -70.12% |
| Mar 31, 2023 | -38.51% |
| Sep 30, 2022 | -34.64% |
| Dec 31, 2021 | -15.66% |
| Sep 30, 2021 | -15.22% |
| Jun 30, 2021 | -46.75% |
| Mar 31, 2021 | -153.84% |
| Sep 30, 2020 | -195.52% |
| Mar 31, 2020 | 159.45% |
| Dec 31, 2019 | 412.69% |
| Sep 30, 2019 | 219.93% |
| Jun 30, 2019 | 0.16% |
| Mar 31, 2019 | 52.54% |
| Dec 31, 2018 | 32.46% |
| Sep 30, 2018 | 30.64% |
| Jun 30, 2018 | -34.80% |
| Mar 31, 2018 | -87.93% |
| Dec 31, 2017 | 14.92% |
| Sep 30, 2017 | -685.15% |
| Jun 30, 2017 | 1.46% |
| Mar 31, 2017 | -46.09% |
| Dec 31, 2016 | -21.77% |
| Sep 30, 2016 | 305.11% |